TSHA EV/EBITDA
-10.76
0.000.00%
Thu, 23 Jan 2025 00:15:25 GMT
Summary:
As of January 23, 2025, TSHA EV/EBITDA is -10.76, unchanged from the previous trading day. Over the past year, it has dropped by -8.86 (-466.32%). TSHA EV/EBITDA is now -11855.56% below its all-time high of -0.09.TSHA EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TSHA EV/EBITDA Performance
PeriodPeriod | EV/EBITDAEV/EBITDA |
---|---|
todaytoday | 0.0% |
1 m1 month | +22.8% |
3 m3 months | +25.9% |
6 m6 months | -263.5% |
ytdytd | +12.2% |
1 y1 year | -466.3% |
5 y5 years | - |
TSHA EV/EBITDA High & Low
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | -10.76 | at high | -15.92 | +32.4% |
3 m | 3-month | -8.09 | -33.0% | -27.82 | +61.3% |
6 m | 6-month | -2.54 | -323.6% | -27.82 | +61.3% |
1 y | 1-year | -1.79 | -501.1% | -27.82 | +61.3% |
3 y | 3-year | -0.09 | <-9999.0% | -27.82 | +61.3% |
5 y | 5-year | -0.09 | <-9999.0% | -31.19 | +65.5% |
alltime | all time | -0.09 | <-9999.0% | -31.19 | +65.5% |
Taysha Gene Therapies EV/EBITDA History
Date | Value |
---|---|
2025 | -10.76(-12.2%) |
2024 | -12.25(+412.6%) |
2023 | -2.39(+236.6%) |
Date | Value |
---|---|
2022 | -0.71(-66.2%) |
2021 | -2.10(-83.2%) |
2020 | -12.52 |
FAQ
- What is Taysha Gene Therapies EV/EBITDA?
- What is the all time high EV/EBITDA for Taysha Gene Therapies?
- What is TSHA EV/EBITDA year-to-date change?
- What is Taysha Gene Therapies EV/EBITDA year-on-year change?
What is Taysha Gene Therapies EV/EBITDA?
The current EV/EBITDA of TSHA is -10.76
What is the all time high EV/EBITDA for Taysha Gene Therapies?
Taysha Gene Therapies all-time high EV/EBITDA is -0.09
What is TSHA EV/EBITDA year-to-date change?
Taysha Gene Therapies EV/EBITDA has changed by +1.49 (+12.16%) since the beginning of the year
What is Taysha Gene Therapies EV/EBITDA year-on-year change?
Over the past year, TSHA EV/EBITDA has changed by -8.86 (-466.32%)